British professional medical body shaping practice and accreditation
MPs are back in the House of Commons facing the Terminally Ill Adults (End of Life) Bill. Supporters argue it offers dying adults a choice with safeguards, while opponents warn of risks to vulnerable people. The government remains neutral. A pivotal vote is expected this Friday, with the outcome likely to hinge on turnout and the Lords’ future role.
England has authorised Enhertu for routine NHS use for HER2‑low metastatic breast cancer, ensuring access for about 1,000 women annually. The decision follows a previous rejection over cost‑effectiveness and builds on a deal between NICE and drug makers AstraZeneca and Daiichi Sankyo. Scotland has already provided access since 2023.